Health outcomes of sexual and gender minorities after cancer: a systematic review.

Publisher: BioMed Central Country of Publication: England NLM ID: 101580575 Publication Model: Electronic Cited Medium: Internet ISSN: 2046-4053 (Electronic) Linking ISSN: 20464053 NLM ISO Abbreviation: Syst Rev Subsets: MEDLINE

Original Publication: London : BioMed Central

Neoplasms*/therapy ; Sexual and Gender Minorities*; Cross-Sectional Studies ; Female ; Gender Identity ; Humans ; Male ; Outcome Assessment, Health Care ; Sexual Behavior

Purpose: Cancer research on sexual and gender minority (SGM) populations is gaining momentum. The purpose of this systematic review was to examine what is currently known in the research literature regarding patient-reported health outcomes after cancer treatment among SGM populations.
Methods: In March 2021, a medical librarian conducted a systematic keyword search on PubMed, Embase, Scopus, Web of Science, PsycINFO, ClinicalTrials.gov , and the Cochrane Central Register of Controlled Trials. The primary inclusion criterion was assessment of at least one physical, psychosocial, emotional, or functional patient-reported health outcome related to the impacts of cancer diagnosis and/or treatment. Articles that met inclusion criteria were reviewed in their entirety, charted in a Word Table, and assessed for quality. Quality considerations included study design, sampling approach, diversity of sample, measures used, and analytic procedures. Studies were synthesized based on type of cancer study participants experienced.
Results: Sixty-four studies were included in the final analysis: most were quantitative, secondary analyses or cross-sectional studies with convenience samples, and focused on people with a history of breast or prostate cancer. Differences between sexual minority men and women in terms of coping and resilience were noted. Few studies reported on experiences of transgender persons and none reported on experiences of intersex persons.
Conclusions: A growing literature describes the patient-reported health outcomes of SGM people with a history of cancer. This study summarizes important between-group differences among SGM and heterosexual, cisgender counterparts that are critical for clinicians to consider when providing care.
Implications for Cancer Survivors: Sexual orientation and gender identity are relevant to cancer survivors' health outcomes. Subgroups of SGM people have differential experiences and outcomes related to cancer and its impacts.

Ann Oncol. 2012 Nov;23(11):2873-2878. (PMID: 22556213)
Urology. 2013 Sep;82(3):565-71. (PMID: 23768520)
LGBT Health. 2015 Mar;2(1):41-7. (PMID: 26790017)
Arch Sex Behav. 2017 Oct;46(7):2043-2057. (PMID: 27102603)
Oncol Nurs Forum. 2017 May 1;44(3):350-357. (PMID: 28635972)
J Homosex. 2014;61(6):889-98. (PMID: 24392702)
J Consult Clin Psychol. 2012 Jun;80(3):382-95. (PMID: 22409643)
Arch Intern Med. 2006 May 22;166(10):1092-7. (PMID: 16717171)
LGBT Health. 2021 Jan;8(1):68-78. (PMID: 33325783)
Soc Psychiatry Psychiatr Epidemiol. 2010 Mar;45(3):405-12. (PMID: 19479171)
Psychooncology. 2013 May;22(5):1050-4. (PMID: 22573471)
J Womens Health (Larchmt). 2011 Dec;20(12):1819-24. (PMID: 21992619)
Med Care. 2001 Oct;39(10):1097-104. (PMID: 11567172)
Support Care Cancer. 2020 Jun;28(6):2769-2778. (PMID: 31724075)
Med Care. 1996 Mar;34(3):220-33. (PMID: 8628042)
J Cancer Surviv. 2011 Mar;5(1):92-101. (PMID: 21165708)
Oncol Nurs Forum. 2012 Mar;39(2):210-7. (PMID: 22374495)
Cancer Invest. 2011 Mar;29(3):220-8. (PMID: 21314331)
Health Psychol. 2001 Jan;20(1):20-32. (PMID: 11199062)
J Psychosoc Oncol. 2018 Jul-Aug;36(4):393-405. (PMID: 29791273)
J Cancer Surviv. 2016 Oct;10(5):802-13. (PMID: 26899851)
Urology. 2007 May;69(5):805-9. (PMID: 17482908)
LGBT Health. 2018 Jul;5(5):295-302. (PMID: 29878863)
Oncol Nurs Forum. 2002 Nov-Dec;29(10):1455-62. (PMID: 12432416)
J Sex Med. 2015 Dec;12(12):2378-86. (PMID: 26537853)
Psychooncology. 2019 Dec;28(12):2351-2357. (PMID: 31518042)
Urology. 1996 Nov;48(5):773-7. (PMID: 8911524)
J Health Psychol. 2020 Mar;25(3):298-310. (PMID: 28810471)
Health Psychol. 2017 Jun;36(6):529-537. (PMID: 28165265)
BMJ. 2021 Mar 29;372:n71. (PMID: 33782057)
EClinicalMedicine. 2020 Sep 24;27:100538. (PMID: 33150319)
Cancer. 2020 Jun 15;126(12):2829-2836. (PMID: 32134515)
Prev Med Rep. 2015;2:283-286. (PMID: 25984441)
LGBT Health. 2018 Apr;5(3):203-211. (PMID: 29641317)
Urology. 1997 Dec;50(6):920-8. (PMID: 9426724)
Am J Clin Oncol. 2020 Sep;43(9):660-666. (PMID: 32889837)
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76. (PMID: 8433390)
J Eval Clin Pract. 2009 Aug;15(4):602-6. (PMID: 19522727)
Psychooncology. 2017 Apr;26(4):500-507. (PMID: 26626273)
J Womens Health (Larchmt). 2019 Aug;28(8):1023-1030. (PMID: 30130140)
J Pers Soc Psychol. 1993 Aug;65(2):350-9. (PMID: 8366424)
Cancer. 2016 Jul 15;122(14):2260-7. (PMID: 27171544)
J Sex Med. 2013 Aug;10(8):2094-100. (PMID: 23742184)
Eur J Cancer Care (Engl). 2013 Jul;22(4):522-9. (PMID: 23730947)
Acta Psychiatr Scand. 1983 Jun;67(6):361-70. (PMID: 6880820)
J Clin Oncol. 2017 Jul 1;35(19):2203-2208. (PMID: 28368670)
LGBT Health. 2014 Jun;1(2):86-92. (PMID: 26789618)
J Nurs Meas. 1993 Winter;1(2):165-78. (PMID: 7850498)
J Sex Marital Ther. 2006 Jan-Feb;32(1):43-52. (PMID: 16234225)
Women Health. 2018 Apr;58(4):403-418. (PMID: 28328308)
Qual Life Res. 2012 Mar;21(2):225-36. (PMID: 21660650)
Psychooncology. 2015 Jun;24(6):691-8. (PMID: 25060033)
Med Care. 2003 Aug;41(8):923-36. (PMID: 12886172)
LGBT Health. 2015 Nov 24;3(1):57-64. (PMID: 26652029)
Psychooncology. 2014 May;23(5):578-84. (PMID: 24285508)
Urology. 2000 Dec 20;56(6):899-905. (PMID: 11113727)
Oncol Nurs Forum. 2015 Jan;42(1):44-51. (PMID: 25542320)
J Sex Res. 2014;51(6):681-9. (PMID: 23730713)
Women Health. 2012;52(1):71-87. (PMID: 22324359)
Psychooncology. 2019 Feb;28(2):442-444. (PMID: 30511405)
Psychol Bull. 1985 Sep;98(2):310-57. (PMID: 3901065)
Sex Relation Ther. 2016;31(4):446-461. (PMID: 27942251)
Scand J Urol. 2019 Feb;53(1):40-44. (PMID: 30727809)
Cancer. 2011 Aug 15;117(16):3796-804. (PMID: 21557209)
J Am Psychiatr Nurses Assoc. 2013 Sep-Oct;19(5):280-92. (PMID: 24055955)
Psychooncology. 2018 Oct;27(10):2389-2397. (PMID: 29959808)
Psychol Med. 1983 Aug;13(3):595-605. (PMID: 6622612)
J Cancer Surviv. 2016 Oct;10(5):935-42. (PMID: 26887847)
Psychooncology. 2015 Nov;24(11):1384-91. (PMID: 25630987)
Cancer. 2003 Jun 1;97(11):2910-8. (PMID: 12767107)
Lancet Oncol. 2012 Dec;13(12):e545-53. (PMID: 23182195)
Support Care Cancer. 2018 Apr;26(4):1189-1196. (PMID: 29080921)
LGBT Health. 2015 Sep;2(3):221-7. (PMID: 26788670)
J Cancer Surviv. 2013 Jun;7(2):203-10. (PMID: 23328868)
Ann Behav Med. 2006 Aug;32(1):77-81. (PMID: 16827632)
Cancer. 2019 Dec 15;125(24):4371-4379. (PMID: 31593319)
J Sex Med. 2016 Mar;13(3):425-34. (PMID: 26853048)
Int J Environ Res Public Health. 2019 Nov 13;16(22):. (PMID: 31766206)
J Sex Marital Ther. 2000 Apr-Jun;26(2):191-208. (PMID: 10782451)
J Clin Epidemiol. 2021 Jun;134:103-112. (PMID: 33577987)
J Med Humanit. 2020 Sep;41(3):341-361. (PMID: 30488328)
LGBT Health. 2015 Nov 13;3(1):79-89. (PMID: 26789402)
Urol Pract. 2018 May;5(3):187-191. (PMID: 35296068)
J Affect Disord. 2009 Apr;114(1-3):163-73. (PMID: 18752852)
J Adolesc Young Adult Oncol. 2021 Apr;10(2):148-155. (PMID: 32730111)
Arch Sex Behav. 2020 Jul;49(5):1589-1600. (PMID: 31016492)
LGBT Health. 2015 Aug 26;3(1):65-73. (PMID: 26789396)
LGBT Health. 2015 Dec 24;3(1):49-56. (PMID: 26698658)
J Pers Soc Psychol. 1991 Aug;61(2):226-44. (PMID: 1920064)
Eur J Cancer Care (Engl). 2018 Mar;27(2):e12827. (PMID: 29461652)
BJU Int. 2011 Jul;108(1):110-5. (PMID: 20955264)
Eur J Oncol Nurs. 2018 Apr;33:62-69. (PMID: 29551179)
Psychooncology. 2016 Nov;25(11):1329-1336. (PMID: 27530377)
Urology. 1997 Jun;49(6):822-30. (PMID: 9187685)
J Sex Marital Ther. 2014;40(3):233-53. (PMID: 23899045)
J Clin Epidemiol. 2012 Oct;65(10):1107-16. (PMID: 22818947)
J Sex Med. 2014 Sep;11(9):2308-17. (PMID: 24888965)
Soc Sci Med. 2013 May;84:22-9. (PMID: 23517700)
Cancer. 2019 Sep 1;125(17):3079-3085. (PMID: 31106409)
Soc Sci Med. 2019 Oct;239:112550. (PMID: 31542648)
Ann Oncol. 2013 Jun;24(6):1622-30. (PMID: 23448806)

Keywords: Cancer survivorship; Gender identity; LGBTQI; Patient-reported outcomes; QOL; Sexual and gender minorities; Sexual orientation

Date Created: 20210622 Date Completed: 20210705 Latest Revision: 20231107

20240105

PMC8218456

10.1186/s13643-021-01707-4

34154645